A Study to Evaluate Long-term Impact of VARIVAX Among Children and Adolescents (V210-036)(COMPLETED)

CompletedOBSERVATIONAL

Enrollment

7,585

Participants

Timeline

Start Date

June 1, 1995

Primary Completion Date

September 1, 2010

Study Completion Date

November 1, 2010

Conditions

VaricellaHerpes Zoster

All Listed Sponsors

collaborator

Kaiser Permanente

OTHER

lead

Merck Sharp & Dohme LLC

INDUSTRY

NCT01077804 - A Study to Evaluate Long-term Impact of VARIVAX Among Children and Adolescents (V210-036)(COMPLETED) | Biotech Hunter | Biotech Hunter